Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials

Grants

Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: TEMPO-2 is funded by grants from Heart and stroke foundation of Canada and Canadian Institute of Health Research. ATTEST-2 is funded by a grant from the Stroke Association and British Heart Foundation. TASTE is funded by grants from the National Health and Medical Research Council of Australia, National Stroke Foundation of Australia, and National Heart Foundation of Australia. TWIST is funded by the Norwegian Ministry of Health and Care Services, the National Association for Public Health, British Heart Foundation, and Swiss Heart Foundation. EXTEND-IA TNK II is funded by grants from the National Health and Medical Research Council of Australia and National Heart Foundation of Australia.